Brief: Egetis Raises SEK 180 Mln Through Rights Issue
May 19 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST :
* EGETIS THERAPEUTICS RAISES APPROXIMATELY SEK 180 MILLION
THROUGH
AN OVERSUBSCRIBED RIGHTS ISSUE
Source text for Eikon: ID:nMFN1LplqX
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1